42 Researchers from the Chula Vaccine Research Centre of Chulalongkorn University s Faculty of Medicine host a press briefing on the progress of the country s first-ever mRNA ChulaCOV 19 vaccine at Chulalongkorn Hospital. (Photo by Somchai Poomlard)
The mRNA ChulaCOV 19 vaccine which Thailand is developing will enter the first stage of human trials in May with hopes to produce a maximum of five million shots with its partner, vaccine manufacturer BioNet Asia, by the end of this year.
It will be followed by the beginning of a cocktail vaccine development, which will be the second vaccine generation to fight the mutated SARS-CoV-2 virus strains in the next two months.
The mRNA vaccine against the coronavirus developed by Chulalongkorn University of Thailand, is scheduled to enter the first stage of human trials soon, according to a university official.
The mRNA vaccine against the coronavirus developed by Chulalongkorn University of Thailand, is scheduled to enter the first stage of human trials soon, according to a university official.In Thursday s press conference, Kiat Ruxrungtham, who is .
Thailand to start clinical trials on homemade COVID-19 vaccine - World News sina.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sina.com Daily Mail and Mail on Sunday newspapers.